A Study of Omalizumab in the Prevention of Allergen Induced Airway

Clinical Trial Summary

This was a multicenter, randomized, double-blind, parallel-group, three-arm, placebo-controlled study designed to demonstrate the efficacy of two different formulations of omalizumab compared with placebo in reducing the airway reaction to an inhaled aeroallergen solution in adult subjects with mild allergic asthma.

See also
Status	Clinical Trial	Phase
Completed	`NCT03850626` - Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients
Completed	`NCT02911688` - Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled O3 Exposure	Phase 2
Active, not recruiting	`NCT01776177` - The REALITY Study - a Real-life Long-term Analysis of Xolair Therapy	N/A
Completed	`NCT00485576` - Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma	Phase 2
Completed	`NCT00736801` - Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma	N/A
Completed	`NCT00515775` - Influence of a Inhaled Corticosteroid Therapy Versus Corticosteroid + LABA Therapy on the FeNO of Asthmatic Children	N/A
Completed	`NCT04259164` - Anti-inflammatory Effects Glycopyrronium	Phase 3
Active, not recruiting	`NCT04619017` - Airway Immune Response to Allergens (Use Lay Language Here)	Phase 1
Completed	`NCT01699594` - Change in Airway Responsiveness After Allergen Exposure	N/A
Completed	`NCT00999466` - The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen	Phase 2
Completed	`NCT01353755` - 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma	Phase 3
Completed	`NCT00492076` - Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma	Phase 4
Completed	`NCT00490425` - Prevention of Asthma and Allergy by Probiotic Lactobacillus GG	Phase 4
Completed	`NCT00829179` - Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma	Phase 3
Recruiting	`NCT04542902` - Non-coding RNAs Analysis of Eosinophil Subtypes in Asthma	N/A
Recruiting	`NCT04109534` - Effect of a Dietary Fatty Acid Supplementation on Symptoms and Bronchial Inflammation in Patients With Asthma	N/A
Active, not recruiting	`NCT05186025` - Tyrosine Allergoid Paediatric and Adult Study
Withdrawn	`NCT03307278` - House Dust Mite Induced Inflammasome Activation on Corticosteroid Resistance	N/A
Enrolling by invitation	`NCT06151938` - Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis
Withdrawn	`NCT04401631` - Analytical Validation of the abioSCOPE Device With an IgE Test Panel: Point-of-Care Precision, Sample Type Comparison and Method Correlation

NCT number	NCT00434434
Study type	Interventional
Source	Genentech, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	October 2007
Completion date	June 2009

A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma — AQUA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms